193 related articles for article (PubMed ID: 10711711)
1. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
[TBL] [Abstract][Full Text] [Related]
3. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
[TBL] [Abstract][Full Text] [Related]
5. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.
Kamei M; Hollyfield JG
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2367-75. PubMed ID: 10476804
[TBL] [Abstract][Full Text] [Related]
6. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.
Majid MA; Smith VA; Newby AC; Dick AD
Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.
Majid MA; Smith VA; Matthews FJ; Newby AC; Dick AD
Br J Ophthalmol; 2006 Oct; 90(10):1310-5. PubMed ID: 16837541
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.
Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
Br J Ophthalmol; 2002 Jan; 86(1):97-101. PubMed ID: 11801512
[TBL] [Abstract][Full Text] [Related]
9. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
[TBL] [Abstract][Full Text] [Related]
10. A mouse model for Sorsby fundus dystrophy.
Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
[TBL] [Abstract][Full Text] [Related]
11. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
Li Z; Clarke MP; Barker MD; McKie N
Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
[TBL] [Abstract][Full Text] [Related]
12. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
[TBL] [Abstract][Full Text] [Related]
13. Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells.
Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
FEBS Lett; 2002 Oct; 529(2-3):281-5. PubMed ID: 12372614
[TBL] [Abstract][Full Text] [Related]
14. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium.
Della NG; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1921-4. PubMed ID: 8759363
[TBL] [Abstract][Full Text] [Related]
15. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
[TBL] [Abstract][Full Text] [Related]
16. Repopulation of different layers of host human Bruch's membrane by retinal pigment epithelial cell grafts.
Tezel TH; Del Priore LV
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):767-74. PubMed ID: 10067982
[TBL] [Abstract][Full Text] [Related]
17. Sorsby's fundus dystrophy. A light and electron microscopic study.
Capon MR; Marshall J; Krafft JI; Alexander RA; Hiscott PS; Bird AC
Ophthalmology; 1989 Dec; 96(12):1769-77. PubMed ID: 2482957
[TBL] [Abstract][Full Text] [Related]
18. Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation.
Sieving PA; Boskovich S; Bingham E; Pawar H
Trans Am Ophthalmol Soc; 1996; 94():275-94; discussion 295-7. PubMed ID: 8981701
[TBL] [Abstract][Full Text] [Related]
19. Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy.
Gourier HC; Chong NV
J Clin Med; 2015 May; 4(5):874-83. PubMed ID: 26239453
[TBL] [Abstract][Full Text] [Related]
20. Analysis of carbohydrate structures in basal laminar deposit in aging human maculae.
Kliffen M; Mooy CM; Luider TM; de Jong PT
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2901-5. PubMed ID: 8206707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
